Melinda French Gates Invests in Women's Midlife Health
Women's health received a major boost this year as philanthropist and women's health advocate Melinda French Gates announced $215 million in new funding focused on women's health initiatives.
The investment is part of a broader effort to address longstanding gaps in women's healthcare, research, and education. Despite affecting roughly half the population, many women's health conditions remain underfunded and understudied compared with other areas of medicine. Menopause, in particular, has historically received limited research attention, leaving many women without adequate information, support, or access to trained healthcare professionals.
Among the recipients is The Menopause Society, which received funding to help improve menopause care and expand access to healthcare professionals trained in menopause management. The funding is expected to support education, awareness, and efforts to improve the quality of care available to women navigating perimenopause and menopause.
French Gates has spoken openly about the need to bring greater attention to women's health across all stages of life, including midlife and menopause. In discussing the challenges facing women's health research, she noted that society still has much to learn about menopause and how hormonal changes affect women during this phase of life.
The investment reflects growing recognition that menopause is not simply a natural life transition but an important health issue that can affect physical, emotional, cognitive, and long-term well-being. Increased funding for research, education, and healthcare access could help ensure that more women receive evidence-based information and appropriate care during the menopause transition and beyond.
This summary (posted June 5, 2026) is based on reporting by Laura Trujillo for USA TODAY, published on MSN.com on
June 4, 2026
Michelle Obama Opens Up About Menopause and Hormone Therapy
Former First Lady Michelle Obama has once again helped bring national attention to menopause by speaking openly about her own experiences with hot flashes, night sweats, weight changes, and hormone therapy.
In recent interviews and podcast discussions, Obama described experiencing intense hot flashes, including one memorable episode aboard Marine One, as well as night sweats that began earlier than many women might expect. She also discussed the gradual weight changes that can occur during perimenopause and menopause, highlighting challenges shared by millions of women.
Obama also spoke about her decision to use hormone replacement therapy (HRT), noting that evolving research has changed how many healthcare professionals view menopause treatment. Hormone therapy is considered one treatment option for women experiencing moderate to severe menopause symptoms, particularly hot flashes and night sweats. However, treatment decisions are highly individual and should always be made in consultation with a qualified healthcare provider.
Current medical guidance suggests that hormone therapy may provide significant benefits for some women when started at the appropriate time and after careful evaluation of personal health history and risk factors.
Michelle Obama's willingness to discuss menopause publicly helps normalize conversations about a life stage that has historically received far too little attention. Her openness encourages women to seek information, ask questions, and explore treatment options with their healthcare providers rather than suffering in silence.
This summary is based on reporting by Samantha Agate (May 15, 2026) for Us Weekly and related coverage.